
Bullfrog AI Holdings: A Maryland-based medical organization, founded in 2020.
Bullfrog AI Holdings, founded in 2020 and based in Gaithersburg, Maryland, is a technology-driven medical organization focused on revolutionizing drug discovery and development. Their core mission is to harness the power of artificial intelligence to identify drug targets that drive disease, thereby advancing the next generation of lifesaving medicines. By operating at the intersection of computational biology and AI, Bullfrog AI aims to streamline and enhance the drug discovery process, targeting a market that includes pharmaceutical companies and research institutions.
Notable affiliates and investors in Bullfrog AI Holdings include key figures in the biotech and AI sectors, though specific names are not mentioned. The company has achieved significant milestones in integrating AI with drug discovery, positioning itself as a pioneer in this innovative field. The overall impact of Bullfrog AI Holdings lies in its potential to accelerate the development of effective treatments for various diseases, ultimately contributing to improved global health outcomes.

Zephyr AI
zephyrai.bio

Bpgbio
bpgbio.com

TandemAI
tandemai.com

Pathos AI
pathos.com

Model Medicines
modelmedicines.com

Biosim

BioAI Health
bioaihealth.com

DeepCure
deepcure.ai

Cognaisent
cognaisent.com

Phronesis Artificial Intelligence
phronesisai.com

Superluminal Medicines
superluminalrx.com

Regenerative Bio
regen-bio.us

AMPLY Discovery
amplydiscovery.com

Insitro
insitro.com

Aureka Biotechnologies
aurekabio.com
Companies similar to Bullfrog AI Holdings include Zephyr AI, Bpgbio, TandemAI and Pathos AI.
Bullfrog AI Holdings was founded in 2020.
Bullfrog AI Holdings' headquarters is located in Gaithersburg, MD, US.
Bullfrog AI Holdings has 4 employees as of Feb 1, 2024.